HIGHLIGHTS
- who: Filipa Mota from the The overall goal of this study was to develop radiolabeled-pretomanid for dynamic, concentration-time profiles using PET to characterize pretomanid brain PK (in animal and human studies) and assess the efficacy of a pretomanid-containing regimen for TB meningitisWe performed cross-species analyses for preclinical validation of , pretomanid as a molecular imaging tool to noninvasively assess whole-body drug penetration and then optimized the radiosynthesis of , pretomanid under cGMP to facilitate the execution of first-in-human studies. Dynamic , pretomanid PET/CT was used to obtain TACs and AUCs by quantifying . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.